Mead Johnson has been the subject of takeover talk ever since it was spun-off from pharma group Bristol-Myers Squibb in 2009. Today's (10 February) news that the board of the US infant formula business has backed a potential sale came as little surprise - but what has raised eyebrows is the seemingly unlikely source of interest, UK condom-to-cleaning product provider Reckitt Benckiser. Katy Askew looks at the potential deal.